Inhibrx, Inc. (61) | Human Resources (23)

Browse by Subcategory

Recent Contracts

Separation Letter Agreement, effective as of February 1, 2022, by and between the Registrant and Klaus Wagner, M.D., Ph.D (Filed With SEC on February 28, 2022)
Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Kelly Deck (Filed With SEC on November 9, 2021)
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on August 12, 2020)
Non-Employee Director Compensation Policy (Filed With SEC on July 28, 2020)
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Brendan Eckelman, Ph.D (Filed With SEC on November 9, 2021)
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Klaus Wagner, M.D., Ph.D (Filed With SEC on November 9, 2021)
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Mark Lappe (Filed With SEC on November 9, 2021)
Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Kelly Deck (Filed With SEC on August 12, 2020)
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Brendan Eckelman, Ph.D (Filed With SEC on August 12, 2020)
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Klaus Wagner, M.D., Ph.D (Filed With SEC on August 12, 2020)
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Mark Lappe (Filed With SEC on August 12, 2020)
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on July 28, 2020)
Amendment to Inhibrx, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect) (Filed With SEC on August 20, 2019)
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on August 20, 2019)
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Klaus Wagner, M.D., Ph.D (Filed With SEC on June 3, 2019)
Form of Restricted Stock Agreement under the Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on June 3, 2019)
Form of Stock Option Grant Notice under the Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on June 3, 2019)
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering) (Filed With SEC on June 3, 2019)
Form of Restricted Stock Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect) (Filed With SEC on June 3, 2019)
Form of Stock Option Grant Notice under the 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect) (Filed With SEC on June 3, 2019)
2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect) (Filed With SEC on June 3, 2019)
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Brendan Eckelman, Ph.D (Filed With SEC on June 3, 2019)
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Mark Lappe (Filed With SEC on June 3, 2019)